Human Genome Epidemiology Literature Finder
Records 1 - 3 (of 3 Records) |
Query Trace: Recurrence and ATG2B[original query] |
---|
Autophagy controls BCG-induced trained immunity and the response to intravesical BCG therapy for bladder cancer. PLoS pathogens 2014 Oct 10 (10): e1004485. Buffen Kathrin, Oosting Marije, Quintin Jessica, Ng Aylwin, Kleinnijenhuis Johanneke, Kumar Vinod, van de Vosse Esther, Wijmenga Cisca, van Crevel Reinout, Oosterwijk Egbert, Grotenhuis Anne J, Vermeulen Sita H, Kiemeney Lambertus A, van de Veerdonk Frank L, Chamilos Georgios, Xavier Ramnik J, van der Meer Jos W M, Netea Mihai G, Joosten Leo A |
Potentially Functional Variants of ATG16L2 Predict Radiation Pneumonitis and Outcomes in Patients with Non-Small Cell Lung Cancer after Definitive Radiotherapy. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2018 Feb . Wen Juyi, Liu Hongliang, Wang Lili, Wang Xiaomeng, Gu Ning, Liu Zhensheng, Xu Ting, Gomez Daniel R, Komaki Ritsuko, Liao Zhongxing, Wei Qing |
Polymorphism in autophagy gene ATG2B is not associated with bladder cancer recurrence after intravesical Bacillus Calmette-Guerin (BCG) immunotherapy in Asian patients. Urologic oncology 2020 Nov . Zang Zhijiang, Lim Yew Koon, Chan Yiong Huak, Raman Lata, Esuvaranathan Kesavan, Chiong Edmund, Mahendran Rat |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: